Lariciresinol-4-O-β-D-glucopyranoside from the root of Isatis indigotica inhibits influenza A virus-induced pro-inflammatory response

Journal of Ethnopharmacology

Volumn 174, Issue , 2015, Pages 379-386

  Li, Jing ^a   Zhou, Beixian ^b   Li, Chufang ^a   Chen, QiaoYan ^c   Wang, Yutao ^a   Li, Zhengtu ^a   Chen, Tingting ^a   Yang, Chunguang ^a   Jiang, Zhihong ^b   Zhong, Nanshan ^a,b   Yang, Zifeng ^a,b   Chen, Rongchang ^a  

^a GUANGZHOU MEDICAL UNIVERSITY   (China)

^b MACAU UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Macao)

^c GUANGZHOU UNIVERSITY OF CHINESE MEDICINE   (China)

Author keywords

Inflammation; Influenza virus; Lariciresinol 4 O D glucopyranoside; Rootof Isatis indigotica

Indexed keywords

ALPHA INTERFERON; ANTIVIRUS AGENT; GAMMA INTERFERON INDUCIBLE PROTEIN 10; GLYCOSIDE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 6; INTERLEUKIN 8; LARICIRESINOL 4 O BETA DEXTRO GLUCOPYRANOSIDE; LIGNAN; MONOCYTE CHEMOTACTIC PROTEIN 1; RIBONUCLEOPROTEIN; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; AUTACOID; GLUCOSIDE; LARICIRESINOL-4'-O-GLUCOPYRANOSIDE; PLANT EXTRACT;

ANTIVIRAL ACTIVITY; ARTICLE; CYTOTOXICITY; HEK293 CELL LINE; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE; INFLUENZA A; INFLUENZA A VIRUS; INFLUENZA A VIRUS (H1N1); ISATIS; ISATIS INDIGOTICA; LUNG ALVEOLUS EPITHELIUM CELL; MEDICINAL PLANT; NONHUMAN; PLANT ROOT; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; ANIMAL; ANTAGONISTS AND INHIBITORS; DOG; DRUG EFFECTS; INFLUENZA A VIRUS (H9N2); ISOLATION AND PURIFICATION; MDCK CELL LINE; METABOLISM;

ANIMALS; DOGS; GLUCOSIDES; HUMANS; INFLAMMATION MEDIATORS; INFLUENZA A VIRUS, H1N1 SUBTYPE; INFLUENZA A VIRUS, H9N2 SUBTYPE; MADIN DARBY CANINE KIDNEY CELLS; PLANT EXTRACTS; PLANT ROOTS;

EID: 84940988599     PISSN: 03788741     EISSN: 18727573     Source Type: Journal    
DOI: 10.1016/j.jep.2015.08.037     Document Type: Article

References (49)

1. J.F. Bermejo-Martin, R. Ortiz de Lejarazu, T. Pumarola, J. Rello, R. Almansa, P. Ramirez, I. Martin-Loeches, D. Varillas, M.C. Gallegos, C. Seron, D. Micheloud, J.M. Gomez, A. Tenorio-Abreu, M.J. Ramos, M.L. Molina, S. Huidobro, E. Sanchez, M. Gordon, V. Fernandez, A. Del Castillo, M.A. Marcos, B. Villanueva, C.J. Lopez, M. Rodriguez-Dominguez, J.C. Galan, R. Canton, A. Lietor, S. Rojo, J.M. Eiros, C. Hinojosa, I. Gonzalez, N. Torner, D. Banner, A. Leon, P. Cuesta, T. Rowe, and D.J. Kelvin Th1 and Th17 hypercytokinemia as early host response signature in severe pandemic influenza Crit. Care 13 2009 R201
2. M.A. Carey, J.A. Bradbury, Y.D. Rebolloso, J.P. Graves, D.C. Zeldin, and D.R. Germolec Pharmacologic inhibition of COX-1 and COX-2 in influenza A viral infection in mice PloS One 5 2010 e11610
3. M. Chen, L. Gan, S. Lin, X. Wang, L. Li, Y. Li, C. Zhu, Y. Wang, B. Jiang, and J. Jiang Alkaloids from the root of Isatis indigotica J. Nat. Prod. 75 2012 1167 1176
4. Y. Chen, W. Liang, S. Yang, N. Wu, H. Gao, J. Sheng, H. Yao, J. Wo, Q. Fang, D. Cui, Y. Li, X. Yao, Y. Zhang, H. Wu, S. Zheng, H. Diao, S. Xia, K.H. Chan, H.W. Tsoi, J.L. Teng, W. Song, P. Wang, S.Y. Lau, M. Zheng, J.F. Chan, K.K. To, H. Chen, L. Li, and K.Y. Yuen Human infections with the emerging avian influenza A H7N9 virus from wet market poultry: clinical analysis and characterisation of viral genome Lancet 381 2013 1916 1925
5. Y. Chi, Y. Zhu, T. Wen, L. Cui, Y. Ge, Y. Jiao, T. Wu, A. Ge, H. Ji, K. Xu, C. Bao, Z. Zhu, X. Qi, B. Wu, Z. Shi, F. Tang, Z. Xing, and M. Zhou Cytokine and chemokine levels in patients infected with the novel avian influenza A (H7N9) virus in China J. infect. Dis. 208 2013 1962 1967
6. S. Davidson, S. Crotta, T.M. McCabe, and A. Wack Pathogenic potential of interferon αβ in acute influenza infection Nat. Commun. 2014 5
7. M.D. De Jong, C.P. Simmons, T.T. Thanh, V.M. Hien, G.J. Smith, T.N. Chau, D.M. Hoang, N.V. Chau, T.H. Khanh, V.C. Dong, P.T. Qui, B.V. Cam, Ha do, Q. Guan, Y. Peiris, J.S. Chinh, N.T. Hien, and T.T. Farrar, J. Fatal outcome of human influenza A (H5N1) is associated with high viral load and hypercytokinemia Nat. Med 12 2006 1203 1207
8. G.F. Gao Influenza and the live poultry trade Science 344 2014 235
9. R. Gazit, R. Gruda, M. Elboim, T.I. Arnon, G. Katz, H. Achdout, J. Hanna, U. Qimron, G. Landau, and E. Greenbaum Lethal influenza infection in the absence of the natural killer cell receptor gene Ncr1 Nat. Immunol. 7 2006 517 523
10. D. Gentile, W. Doyle, T. Whiteside, P. Fireman, F.G. Hayden, and D. Skoner Increased interleukin-6 Levels in nasal lavage samples following experimental Influenza A virus infection Clin. Diagn. Lab. Immunol. 5 1998 604 608
11. M. Goritzka, L.R. Durant, C. Pereira, S. Salek-Ardakani, P.J. Openshaw, and C. Johansson Alpha/beta interferon receptor signaling amplifies early proinflammatory cytokine production in the lung during respiratory syncytial virus infection J. Virol. 88 2014 6128 6136
12. N. Hagau, A. Slavcovici, D.N. Gonganau, S. Oltean, D.S. Dirzu, E.S. Brezoszki, M. Maxim, C. Ciuce, M. Mlesnite, and R.L. Gavrus Clinical aspects and cytokine response in severe H1N1 influenza A virus infection Crit. Care 14 2010 R203
13. F.G. Hayden, R. Fritz, M.C. Lobo, W. Alvord, W. Strober, and S.E. Straus Local and systemic cytokine responses during experimental human influenza A virus infection. Relation to symptom formation and host defense J. Clin. Investig. 101 1998 643 649
14. L. He, W. Dong, J. Yang, X. Li, and W. Li Chemical constituents in antiviral fraction of Isatidis Radix and their activities Chin. Tradit. Herb. Drugs 44 2013 2960 2964
15. Y. He, J. Lu, and R.-c Lin Studies on chemical constituents in root of Isatis indigotica Chin. Tradit. Herb. Drugs 34 2003 777 778
16. C.F. Hsieh, C.W. Lo, C.H. Liu, S. Lin, H.R. Yen, T.Y. Lin, and J.T. Horng Mechanism by which ma-xing-shi-gan-tang inhibits the entry of influenza virus J. Ethnopharmacol. 143 2012 57 67
17. L. Kaiser, R.S. Fritz, S.E. Straus, L. Gubareva, and F.G. Hayden Symptom pathogenesis during acute influenza: interleukin-6 and other cytokine responses J. Med. Virol. 64 2001 262 268
18. N. Kumar, Z.T. Xin, Y. Liang, and H. Ly NF-kappaB signaling differentially regulates influenza virus RNA synthesis J. Virol. 82 2008 9880 9889
19. A.H. Law, D.C. Lee, K.Y. Yuen, M. Peiris, and A.S. Lau Cellular response to influenza virus infection: a potential role for autophagy in CXCL10 and interferon-alpha induction Cell. Mol. Immunol. 7 2010 263 270
20. A.K. Lee, S.H. Sung, Y.C. Kim, and S.G. Kim Inhibition of lipopolysaccharide-inducible nitric oxide synthase, TNF-alpha and COX-2 expression by sauchinone effects on I-kappaBalpha phosphorylation, C/EBP and AP-1 activation Br. J. Pharmacol 139 2003 11 20
21. S. Lee, S. Shin, H. Kim, S. Han, K. Kim, J. Kwon, J.H. Kwak, C.K. Lee, N.J. Ha, and D. Yim Anti-inflammatory function of arctiin by inhibiting COX-2 expression via NF-kappaB pathways J. Inflamm. (Lond.) 8 2011 16
22. L. Li, C. Qiao, X. Li, and T. Dong Study of quality control on herbal drugs and preparations of daqingye and banlangen China J. Chin. Mater. Med. 28 1992 229 233
23. Y. Lin, M. Shaw, V. Gregory, K. Cameron, W. Lim, A. Kilmov, K. Subbarao, Y. Guan, S. Krauss, and K. Shortridge Avian-to-human transmission of H9N2 subtype influenza A viruses: relationship between H9N2 and H5N1 human isolates Proc. Natl. Acad. Sci. 97 2000 9654 9658
24. K.J. Livak, and T.D. Schmittgen Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method Methods 25 2001 402 408
25. S. Ludwig Targeting cell signalling pathways to fight the flu: towards a paradigm change in anti-influenza therapy J. Antimicrob. Chemother. 64 2009 1 4
26. W.D. MacRae, and G.H.N. Towers Biological activities of lignins, phytochemistry Phytochemistry 23 1984 1207 1220
27. M.N. Matrosovich, S. Krauss, and R.G. Webster H9N2 influenza A viruses from poultry in Asia have human virus-like receptor specificity Virology 281 2001 156 162
28. I. Mazur, W.J. Wurzer, C. Ehrhardt, S. Pleschka, P. Puthavathana, T. Silberzahn, T. Wolff, O. Planz, and S. Ludwig Acetylsalicylic acid (ASA) blocks influenza virus propagation via its NF-kappaB-inhibiting activity Cell. Microbiol. 9 2007 1683 1694
29. C. McCaughey Influenza:a virus of our times UlsterMed. Soc. 79 2010 46 51
30. F. Nimmerjahn, D. Dudziak, U. Dirmeier, G. Hobom, A. Riedel, M. Schlee, L.M. Staudt, A. Rosenwald, U. Behrends, G.W. Bornkamm, and J. Mautner Active NF-kappaB signalling is a prerequisite for influenza virus infection J. Gen. Virol. 85 2004 2347 2356
31. B. Opitz, V. van Laak, J. Eitel, and N. Suttorp Innate immune recognition in infectious and noninfectious diseases of the lung Am. J. Respir. Crit. Care Med. 181 2010 1294 1309
32. S.G. Paquette, D. Banner, Z. Zhao, Y. Fang, S.S. Huang, A.J. Leomicronn, D.C. Ng, R. Almansa, I. Martin-Loeches, P. Ramirez, L. Socias, A. Loza, J. Blanco, P. Sansonetti, J. Rello, D. Andaluz, B. Shum, S. Rubino, R.O. de Lejarazu, D. Tran, G. Delogu, G. Fadda, S. Krajden, B.B. Rubin, J.F. Bermejo-Martin, A.A. Kelvin, and D.J. Kelvin Interleukin-6 is a potential biomarker for severe pandemic H1N1 influenza A infection PloS One 7 2012 e38214
33. S. Parhira, Z.F. Yang, G.Y. Zhu, Q.L. Chen, B.X. Zhou, Y.T. Wang, L. Liu, L.P. Bai, and Z.H. Jiang In vitro anti-influenza virus activities of a new lignan glycoside from the latex of Calotropis gigantea PloS One 9 2014 e104544
34. E.K. Pauli, M. Schmolke, T. Wolff, D. Viemann, J. Roth, J.G. Bode, and S. Ludwig Influenza A virus inhibits type I IFN signaling via NF-kappaB-dependent induction of SOCS-3 expression PLoS Pathog. 4 2008 e1000196
35. L.A. Perrone, K.J. Szretter, J.M. Katz, J.P. Mizgerd, and T.M. Tumpey Mice lacking both TNF and IL-1 receptors exhibit reduced lung inflammation and delay in onset of death following infection with a highly virulent H5N1 virus J. Infect. Dis. 202 2010 1161 1170
36. R. Pinto, S. Herold, L. Cakarova, K. Hoegner, J. Lohmeyer, O. Planz, and S. Pleschka Inhibition of influenza virus-induced NF-kappaB and Raf/MEK/ERK activation can reduce both virus titers and cytokine expression simultaneously in vitro and in vivo Antivir. Res. 92 2011 45 56
37. L.J. Reed., and H. Muench a simple method of estimating fifty percent endpoints Am. J. Hyg. 27 1938 493 497
38. T. Reiberger, J.H. Aberle, M. Kundi, N. Kohrgruber, A. Rieger, A. Gangl, H. Holzmann, and M. Peck-Radosavljevic IP-10 correlates with hepatitis C viral load, hepatic inflammation and fibrosis and predicts hepatitis C virus relapse or non-response in HIV-HCV coinfection Antivir. Ther. 13 2008 969 976
39. M. Rincon, and C.G. Irvin Role of IL-6 in asthma and other inflammatory pulmonary diseases Int. J. Biol. Sci 8 2012 1281 1290
40. R. Salomon, E. Hoffmann, and R.G. Webster Inhibition of the cytokine response does not protect against lethal H5N1 influenza infection Proc. Natl. Acad. Sci. USA 104 2007 12479 12481
41. A. Shahangian, E.K. Chow, X. Tian, J.R. Kang, A. Ghaffari, S.Y. Liu, J.A. Belperio, G. Cheng, and J.C. Deng Type I IFNs mediate development of postinfluenza bacterial pneumonia in mice J. Clin. Investig. 119 2009 1910 1920
42. N. Svitek, P.A. Rudd, K. Obojes, S. Pillet, and V. von Messling Severe seasonal influenza in ferrets correlates with reduced interferon and increased IL-6 induction Virology 376 2008 53 59
43. M. Vitiello, M. Galdiero, E. Finamore, and S. Galdiero NF-kappaB as a potential therapeutic target in microbial diseases Mol. BioSyst. 8 2012 1108 1120
44. W. Wang, P. Yang, Y. Zhong, Z. Zhao, L. Xing, Y. Zhao, Z. Zou, Y. Zhang, C. Li, T. Li, C. Wang, Z. Wang, X. Yu, B. Cao, X. Gao, J.M. Penninger, X. Wang, and C. Jiang Monoclonal antibody against CXCL-10/IP-10 ameliorates influenza A (H1N1) virus induced acute lung injury Cell Res. 23 2013 577 580
45. W.J. Wurzer, C. Ehrhardt, S. Pleschka, F. Berberich-Siebelt, T. Wolff, H. Walczak, O. Planz, and S. Ludwig NF-kappaB-dependent induction of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) and Fas/FasL is crucial for efficient influenza virus propagation J Biol. Chem. 279 2004 30931 30937
46. W.J. Wurzer, O. Planz, C. Ehrhardt, M. Giner, T. Silberzahn, S. Pleschka, and S. Ludwig Caspase 3 activation is essential for efficient influenza virus propagation EMBO J. 22 2003 2717 2728
47. Z. Yang, Y. Wang, Z. Zheng, S. Zhao, J. Zhao, Q. Lin, C. Li, Q. Zhu, and N. Zhong Antiviral activity of Isatis indigotica root-derived clemastanin B against human and avian influenza A and B viruses in vitro Int. J. Mol. Med 31 2013 867 873
48. J.H. Yoo, H.J. Lee, K. Kang, E.H. Jho, C.Y. Kim, D. Baturen, J. Tunsag, and C.W. Nho Lignans inhibit cell growth via regulation of Wnt/beta-catenin signaling Food Chem. Toxicol 48 2010 2247 2252
49. J. Zhou, H.K. Law, C.Y. Cheung, I.H. Ng, J.S. Peiris, and Y.L. Lau Differential expression of chemokines and their receptors in adult and neonatal macrophages infected with human or avian influenza viruses J. Infect. Dis. 194 2006 61 70